ArticleFrontiers in oncology2022

Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.

Jens von der Grün et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.